Aspirin and Extended-Release Dipyridamole
Aspirin and extended-release dipyridamole is a combination antiplatelet medication used to reduce the risk of stroke in people who have already had a transient ischemic attack (TIA) or ischemic stroke.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 4 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Aspirin and Extended-Release Dipyridamole: Patient Information Guide
A plain-language walkthrough of Aspirin and Extended-Release Dipyridamole — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Aspirin and extended-release dipyridamole is a combination antiplatelet medication approved for one main purpose across both its capsule forms:
- Reducing the risk of stroke in people who have already experienced a transient ischemia of the brain (TIA, or "mini-stroke") or a completed ischemic stroke caused by a blood clot (thrombosis).
⚙️How it works▾
This medication works through two separate but complementary pathways — and that's exactly why the combination is more effective than either ingredient alone. Dipyridamole works by blocking the uptake of adenosine into platelets and by inhibiting an enzyme called phosphodiesterase (PDE); together, these actions raise chemical signals inside platelets that tell them to stay inactive and not clump together. Aspirin permanently disables a different enzyme — cyclooxygenase — inside platelets, stopping them from making thromboxane A2, a chemical that normally triggers platelet clumping and blood vessel narrowing. By targeting two different steps in the clotting process, the combination provides additive protection against the kind of clots that can block blood flow to the brain.
💊How it's taken▾
Both the capsule and the extended-release capsule forms are taken orally twice a day — one in the morning and one in the evening. Capsules must be swallowed whole (do not chew) and can be taken with or without food. If headaches are intolerable when starting treatment, your prescriber may temporarily adjust the schedule to one capsule at bedtime; the goal is to return to the standard twice-daily routine within about one week as headaches typically ease with continued use.
- Do not substitute this combination product with separate aspirin tablets and dipyridamole tablets — they are not interchangeable.
- Always follow your prescriber's specific instructions for your situation.
🤒Side effects — in detail▾
The most commonly reported side effects — occurring in more than 1 in 10 patients — include:
- Headache — the most frequent complaint, especially early in treatment
- Upset stomach or heartburn (dyspepsia)
- Abdominal pain
- Nausea
- Diarrhea
- Vomiting
- Dizziness
- Unusual bleeding (e.g., nosebleeds, easy bruising)
Seek prompt medical attention for signs of serious bleeding — such as black or tarry stools, vomiting blood, or bleeding that won't stop — or for chest pain, sudden severe headache, fainting, or signs of an allergic reaction like facial swelling or difficulty breathing.
⚠️Warnings & precautions▾
- Increased bleeding risk: This is the most important safety concern. The risk is higher if you also use blood thinners, other antiplatelet drugs, NSAIDs, or drink heavily. Watch for stomach or intestinal bleeding (black stools, stomach pain) and signs of bleeding in the brain (sudden severe headache, weakness, confusion).
- Pregnancy: Avoid use in the third trimester — aspirin can cause serious harm to the unborn baby, including low birth weight, bleeding complications, and in rare cases, stillbirth or neonatal death. Talk to your doctor before using this medication if you are pregnant or planning to become pregnant.
- Children and teenagers: Do not use in children or teens with a viral illness — the aspirin component raises the risk of Reye syndrome, a rare but life-threatening condition affecting the brain and liver.
- Coronary artery disease: Dipyridamole widens blood vessels and can trigger or worsen chest pain in people with coronary artery disease. Also, the aspirin dose in this product may not be sufficient to protect against heart attack or angina on its own.
- Low blood pressure: Dipyridamole can lower blood pressure; use with care if you already have hypotension.
- Severe kidney or liver disease: Avoid this medication in patients with severe kidney failure or significant liver disease.
🔀What it interacts with▾
This medication interacts with a number of commonly used drugs and substances — always give your prescriber and pharmacist a full list of everything you take:
- Blood thinners (warfarin, heparin): Aspirin adds to their effect, significantly raising bleeding risk.
- Other antiplatelet drugs and anagrelide: Combined use increases bleeding risk further.
- NSAIDs (ibuprofen, naproxen, etc.): Concurrent use may increase bleeding and can reduce kidney function.
- Adenosine / regadenoson: Dipyridamole raises their blood and cardiovascular effects; dosing adjustment may be needed, especially around stress testing.
- ACE inhibitors: Aspirin may blunt the blood pressure-lowering effect of these heart medications.
- Beta blockers and diuretics: Aspirin may reduce the effectiveness of both by affecting kidney prostaglandins.
- Methotrexate: Aspirin can increase methotrexate levels, raising the risk of serious bone marrow toxicity — especially in older adults or those with kidney problems.
- Oral diabetes medications: Aspirin may enhance their glucose-lowering effect, potentially causing low blood sugar.
- Phenytoin / valproic acid (seizure medications): Aspirin can alter blood levels of these drugs.
- Cholinesterase inhibitors (used in myasthenia gravis or dementia): Dipyridamole may counteract their effect.
- Alcohol (3+ drinks daily): Increases bleeding risk when combined with aspirin.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your prescriber about any known allergy to aspirin, NSAIDs, or any ingredient in this product — allergic reactions can be severe, including hives, swelling, or breathing trouble.
- Do not take this medication if you have asthma, nasal polyps, and chronic nasal inflammation together (a condition called aspirin-exacerbated respiratory disease).
- Do not give to children or teenagers with a viral illness (such as flu or chickenpox) — risk of Reye syndrome.
- Avoid during the third trimester of pregnancy; discuss use during earlier trimesters with your doctor, as fetal harm is possible.
- If breastfeeding, discuss with your doctor — both dipyridamole and aspirin's breakdown product (salicylic acid) pass into breast milk.
- Avoid if you have severe kidney failure (very low kidney filtration rate); use with caution and discuss with your prescriber if you have any kidney disease.
- Use with caution if you have liver disease — dipyridamole has been linked to elevated liver enzymes and, in rare cases, liver failure.
- If you have coronary artery disease or low blood pressure, let your prescriber know — dipyridamole's vessel-widening effect can worsen these conditions.
- Older adults may have higher dipyridamole levels in their blood; your prescriber should be aware of your age and any other health conditions.
🚑If you take too much▾
An overdose of this combination is likely to show signs of dipyridamole toxicity first — including flushing, sweating, restlessness, weakness, dizziness, a drop in blood pressure, and a fast heartbeat. Too much aspirin can cause ringing in the ears (tinnitus), fever, and in severe cases, dangerous changes in body chemistry.
If you suspect an overdose, call 911 or contact Poison Control immediately (1-800-222-1222 in the US). Do not wait for symptoms to worsen — prompt medical care is essential.
📡Pharmacodynamics — effects in the body▾
Both aspirin and dipyridamole work by reducing the ability of platelets (tiny blood cells) to clump together and form clots. Dipyridamole does this by raising the level of chemical messengers inside platelets that keep them inactive, blocking their response to several clot-triggering signals. Aspirin permanently disables a key clotting enzyme in platelets, preventing production of a clot-promoting chemical called thromboxane A2. Together, their antiplatelet effects add up, providing greater clot prevention than either drug alone.
🔬Pharmacokinetics — how your body processes it▾
After an oral dose, dipyridamole from this combination reaches peak blood levels in about 2 hours on average, and it is almost completely bound to proteins in the bloodstream. It is broken down mainly in the liver and eliminated primarily through bile and stool. Aspirin is absorbed faster — typically within 30–60 minutes — and is converted in the liver and gut to salicylic acid; it and its byproducts are eliminated through the urine. Older adults tend to have higher dipyridamole levels in their blood compared to younger patients. Taking the capsules with a high-fat meal slightly reduces dipyridamole absorption, but this is not considered clinically meaningful.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) . Protect from excessive moisture.
📄 Written from Aspirin and Extended-Release Dipyridamole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Aspirin and Extended-Release Dipyridamole — the kind of thing our pharmacy team would talk through with you at the counter.
Why did my doctor prescribe this instead of just regular aspirin? ▾
I have a really bad headache since starting this medication — is that normal? Should I stop taking it? ▾
Can I take ibuprofen or other over-the-counter pain relievers while I'm on this? ▾
Are there any signs of bleeding I should watch out for? ▾
Is it safe to take this if I'm pregnant or trying to get pregnant? ▾
Do I need to swallow the capsule whole, or can I open it or chew it? ▾
Is Aspirin and Extended-Release Dipyridamole available over the counter? ▾
When was Aspirin and Extended-Release Dipyridamole first available? ▾
Who makes Aspirin and Extended-Release Dipyridamole? ▾
💬 Answers drafted from Aspirin and Extended-Release Dipyridamole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Aspirin and Extended-Release Dipyridamole comes
Aspirin and Extended-Release Dipyridamole is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Capsule
How this form is used
- Aspirin and Extended-Release Dipyridamole capsules are used to reduce the risk of stroke in people who have had a TIA or ischemic stroke caused by a blood clot.
- Aspirin and Extended-Release Dipyridamole capsules are taken by mouth twice daily — one in the morning and one in the evening.
- Swallow Aspirin and Extended-Release Dipyridamole capsules whole; do not chew.
- Aspirin and Extended-Release Dipyridamole capsules may be taken with or without food.
- Aspirin and Extended-Release Dipyridamole capsules are not interchangeable with separate aspirin and dipyridamole tablets.
Extended-release capsule
How this form is used
- Aspirin And Extended-release Dipyridamole extended-release capsules are indicated to reduce the risk of stroke in patients who have had a TIA or completed ischemic stroke due to a blood clot.
- Aspirin And Extended-release Dipyridamole extended-release capsules are taken by mouth twice daily — once in the morning and once in the evening.
- Swallow Aspirin And Extended-release Dipyridamole extended-release capsules whole; do not chew.
- Aspirin And Extended-release Dipyridamole extended-release capsules may be taken with or without food.
- If headaches during early treatment are unbearable, ask your prescriber about temporarily switching to one capsule at bedtime; plan to return to the twice-daily schedule within about one week.
📊 Aspirin and Extended-Release Dipyridamole across the U.S. market
How Aspirin and Extended-Release Dipyridamole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Aspirin and Extended-Release Dipyridamole is used
A general measure of how commonly Aspirin and Extended-Release Dipyridamole is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Aspirin and Extended-Release Dipyridamole is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Aspirin and Extended-Release Dipyridamole prescribed? Of the 1,594 medications we measure, Aspirin and Extended-Release Dipyridamole ranks #1,416 by Medicaid prescriptions — more than 11% of them.
Utilization by Aspirin and Extended-Release Dipyridamole product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
Other Aspirin and Extended-Release Dipyridamole products — combination packs and listings not yet matched to a specific clinical product (kept visible so every prescription is accounted for)
Summed across the 2 of 4 listed NDC products with Medicaid activity.
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Aspirin and Extended-Release Dipyridamole, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 2 of 4 listed Aspirin and Extended-Release Dipyridamole NDCs with Medicaid activity.
🔍 Compare Aspirin and Extended-Release Dipyridamole products
A representative set of FDA-listed product records for Aspirin and Extended-Release Dipyridamole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 25; 200 mg/1; mg | Oral | Amneal Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg | Oral | AvKARE | ANDA | View NDC → |
| 25; 200 mg/1; mg | Oral | AvKARE × 2 listings | ANDA | View NDC → |
| 💊Extended-release capsule | ||||
| ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg | Oral | Micro Labs Limited | ANDA | View NDC → |
| 25; 200 mg/1; mg | Oral | Micro Labs Limited × 2 listings | ANDA | View NDC → |
Showing 10 of 10 products — FDA National Drug Code Directory. See every product, package size and price: browse all 10 Aspirin and Extended-Release Dipyridamole NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Aspirin and Extended-Release Dipyridamole — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Aspirin and Extended-Release Dipyridamole in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Aspirin and Extended-Release Dipyridamole went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
📦 Supply & shortage status
Whether Aspirin and Extended-Release Dipyridamole is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏭 Manufacturers & labelers
RxNorm drug class
Aspirin and Extended-Release Dipyridamole belongs to the Platelet Aggregation Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 4 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. AvKARE is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.